Drug intelligence / Profile preview

Lactéol Hydro

Development stage: Unknown
Lead developer: DSM-Firmenich
Modality: Small Molecules
Administration: Oral

Overview

Lactéol Hydro is an oral rehydration supplement developed by Laboratoire du Lactéol (an Adare Pharma Solutions company). It is specifically formulated as an oral rehydration solution (ORS) to compensate for the loss of water and electrolytes in infants and young children suffering from acute diarrhea. The product typically consists of a balanced mixture of glucose and electrolytes (sodium, potassium, chloride, and citrate), which leverages the sodium-glucose cotransport mechanism in the intestinal epithelium to promote water absorption. It is marketed as a dietary supplement or food for special medical purposes rather than a pharmaceutical drug.

Brand names: Lactéol Hydro
Other names: Lacteol Hydro

Targets

SLC superfamily (Solute carrier superfamily)

Beyond the preview

Go deeper on Lactéol Hydro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactéol Hydro.

Explore the full profile